1 GENVOYA (ELVITEG/COB/EMTRI/TENOF ALAFEN) | 40 of 170 | 2000 prescriptions Less than 1% of all prescriptions | 710 | 280 patients 36% of all patients | < 11 | |
2 ODEFSEY (EMTRICITAB/RILPIVIRI/TENOF ALA) | 30 of 120 | 1020 prescriptions Less than 1% of all prescriptions | 310 | 140 patients 18% of all patients | < 11 | |
3 TRIUMEQ (ABACAVIR/DOLUTEGRAVIR/LAMIVUDI) | 70 of 150 | 450 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
4 DESCOVY (EMTRICITABINE/TENOFOV ALAFENAM) | 120 of 140 | 280 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
5 ACYCLOVIR | 260 of 1630 | 260 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
6 TIVICAY (DOLUTEGRAVIR SODIUM) | 140 of 170 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 PREZCOBIX (DARUNAVIR/COBICISTAT) | 150 of 170 | 170 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
8 TRUVADA (EMTRICITABINE/TENOFOVIR (TDF)) | 120 of 160 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 STRIBILD (ELVITEG/COB/EMTRI/TENOFO DISOP) | 20 of 30 | 140 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
10 LAMIVUDINE-ZIDOVUDINE (LAMIVUDINE/ZIDOVUDINE) | 20 of 30 | 130 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |